肾炎清片对无症状性血尿患者IL-6和VEGF水平的影响  

Influence of Shenyanqing Tablet on the Serum IL-6 and VEGF Levels in Patients with Asymptomatic Hematuria

作　　者：马亚秋 刘征[2] 宋明辉[2] 谢永新[2] 王明翠[2] 马路[2] 

机构地区：[1]天津中医药大学,天津300073 [2]北京军区北戴河疗养院中国人民解放军中西医结合肾病治疗中心,河北秦皇岛066100

出　　处：《标记免疫分析与临床》2014年第6期688-690,共3页Labeled Immunoassays and Clinical Medicine

摘　　要：目的探讨肾炎清片对无症状性血尿患者IL-6和VEGF水平的影响。方法将76例临床诊断为无症状性血尿患者随机分为治疗组和对照组各38例,对照分析肾炎清片治疗前和治疗后无症状血尿患者的IL-6和VEGF的水平。结果肾炎清片治疗组无症状生血尿患者的IL6和VEGF的水平较对照组明显降低,结果显示组间的差异具有统计学意义(P<0.05)。结论肾炎清片能够改变无症状性血尿患者IL-6和VEGF的水平,可能对无症状性血尿患者血尿症状的改善具有一定的作用。Objective To explore the influence of Shenyanqing Tablet on serum IL-6 and VEGF levels in patients with asymptomatic hematuria. Methods 76 cases of renal hematuria patients diagnosed by renal biopsy were randomly divided into treatment group and control group（ n = 38 in each group）. The serum levels of IL-6 and VEGF before and after treatment by Shenyanqing Tablet in patients with asymptomatic hematuria were detected. Results The serum levels of IL-6 and VEGF in treatment group were significantly lower than that of control group（P 〈 0.05 ）. Conclusion Shenyanqing Tablet could change the serum levels of IL-6 and VEGF in patients with asymptomatichematuria, and it may have a certain effect on the improvement of hematuria symptom in the patients with asymptomatic hematuria.

关 键 词：无症状性血尿 IL-6 VEGF 肾炎清片 

分 类 号：R696.8[医药卫生—泌尿科学]